News & Updates

Use of low-dose aspirin appears to have a null effect on the 5-year survival of patients who undergo gastrectomy for gastric adenocarcinoma, a study reports.

Genetically predicted circulating antioxidants do not appear to have a protective effect on the risk of breast cancer, ovarian cancer, or their histotypes, according to the results of a two-sample Mendelian randomization study.

Treatment-naïve patients with locally advanced or metastatic EGFR-mutated (EGFRm) non-small-cell lung cancer (NSCLC) experience improved progression-free survival (PFS) when treated with furmonertinib compared with gefitinib, according to results of the phase III FURLONG study.

In patients with localized prostate cancer (PCa), higher tumour volume (TV) appears to cut biochemical recurrence-free survival short, a recent study has found.

Findings from the SPOTLIGHT trial have shown the efficacy of administering durvalumab after chemoradiotherapy (CRT) in patients with unresectable stage III non-small-cell lung cancer (NSCLC).

High resting energy expenditure (REE) contributes to an increase in the risk of invasive breast cancer among postmenopausal women, as reported in a study.

Men who carry the G allele of melatonin receptor 1B gene (MTNR1B) rs10830963 are at lower risk of prostate cancer when exposed to night shift work, according to a study.

Income and several clinical factors are associated with placement and retrieval of inferior vena cava filter for patients with cancer-related thrombosis, a study has found. In addition, filter retrieval rates remain low despite reinitiation of anticoagulation in many patients.